JP2009518132A - 軟骨修復方法 - Google Patents
軟骨修復方法 Download PDFInfo
- Publication number
- JP2009518132A JP2009518132A JP2008544482A JP2008544482A JP2009518132A JP 2009518132 A JP2009518132 A JP 2009518132A JP 2008544482 A JP2008544482 A JP 2008544482A JP 2008544482 A JP2008544482 A JP 2008544482A JP 2009518132 A JP2009518132 A JP 2009518132A
- Authority
- JP
- Japan
- Prior art keywords
- joint
- repairing
- membrane
- cartilage defect
- hyaline cartilage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 101
- 210000000845 cartilage Anatomy 0.000 title claims abstract description 27
- 230000008439 repair process Effects 0.000 title description 11
- 239000012528 membrane Substances 0.000 claims abstract description 85
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 72
- 239000005017 polysaccharide Substances 0.000 claims abstract description 72
- 229920000728 polyester Polymers 0.000 claims abstract description 70
- 230000007547 defect Effects 0.000 claims abstract description 53
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 51
- 210000003035 hyaline cartilage Anatomy 0.000 claims abstract description 47
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims abstract description 33
- 238000005553 drilling Methods 0.000 claims abstract description 13
- 238000005299 abrasion Methods 0.000 claims abstract 2
- 150000004804 polysaccharides Chemical class 0.000 claims description 70
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 35
- 229920002674 hyaluronan Polymers 0.000 claims description 35
- 229960003160 hyaluronic acid Drugs 0.000 claims description 35
- 229920000954 Polyglycolide Polymers 0.000 claims description 29
- 239000004633 polyglycolic acid Substances 0.000 claims description 28
- 239000004626 polylactic acid Substances 0.000 claims description 27
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 26
- 238000011282 treatment Methods 0.000 claims description 21
- 239000003102 growth factor Substances 0.000 claims description 20
- 229920001577 copolymer Polymers 0.000 claims description 14
- 210000001519 tissue Anatomy 0.000 claims description 13
- 102000008186 Collagen Human genes 0.000 claims description 12
- 108010035532 Collagen Proteins 0.000 claims description 12
- 239000000853 adhesive Substances 0.000 claims description 12
- 230000001070 adhesive effect Effects 0.000 claims description 12
- 229920001436 collagen Polymers 0.000 claims description 12
- 241000124008 Mammalia Species 0.000 claims description 11
- 229920002971 Heparan sulfate Polymers 0.000 claims description 10
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims description 8
- 108010071942 Colony-Stimulating Factors Proteins 0.000 claims description 7
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 7
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 7
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 7
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 7
- 108010063738 Interleukins Proteins 0.000 claims description 7
- 102000015696 Interleukins Human genes 0.000 claims description 7
- 230000004927 fusion Effects 0.000 claims description 7
- 102000003693 Hedgehog Proteins Human genes 0.000 claims description 6
- 108090000031 Hedgehog Proteins Proteins 0.000 claims description 6
- 241000282414 Homo sapiens Species 0.000 claims description 6
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 6
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 6
- -1 dextran sulfate Polymers 0.000 claims description 6
- 229940126864 fibroblast growth factor Drugs 0.000 claims description 6
- 230000002188 osteogenic effect Effects 0.000 claims description 6
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 6
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 5
- 102100027400 A disintegrin and metalloproteinase with thrombospondin motifs 4 Human genes 0.000 claims description 5
- 101710100373 A disintegrin and metalloproteinase with thrombospondin motifs 4 Proteins 0.000 claims description 5
- 108010059616 Activins Proteins 0.000 claims description 5
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 5
- 229920000045 Dermatan sulfate Polymers 0.000 claims description 5
- 229920002307 Dextran Polymers 0.000 claims description 5
- 229920000288 Keratan sulfate Polymers 0.000 claims description 5
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 5
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 5
- 239000000488 activin Substances 0.000 claims description 5
- 210000001185 bone marrow Anatomy 0.000 claims description 5
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 5
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims description 5
- 229940051593 dermatan sulfate Drugs 0.000 claims description 5
- 229960002086 dextran Drugs 0.000 claims description 5
- 229960000633 dextran sulfate Drugs 0.000 claims description 5
- 230000004069 differentiation Effects 0.000 claims description 5
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 claims description 5
- 230000005012 migration Effects 0.000 claims description 5
- 238000013508 migration Methods 0.000 claims description 5
- 102100026818 Inhibin beta E chain Human genes 0.000 claims description 4
- 229960001126 alginic acid Drugs 0.000 claims description 4
- 229920000615 alginic acid Polymers 0.000 claims description 4
- 235000010443 alginic acid Nutrition 0.000 claims description 4
- 239000000783 alginic acid Substances 0.000 claims description 4
- 150000004781 alginic acids Chemical class 0.000 claims description 4
- 238000011882 arthroplasty Methods 0.000 claims description 4
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 claims description 3
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 claims description 3
- 238000004873 anchoring Methods 0.000 claims description 3
- 210000000629 knee joint Anatomy 0.000 claims description 3
- 102000013275 Somatomedins Human genes 0.000 claims description 2
- 210000000130 stem cell Anatomy 0.000 claims description 2
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 210000000968 fibrocartilage Anatomy 0.000 abstract description 7
- 238000001356 surgical procedure Methods 0.000 abstract description 7
- 150000004676 glycans Chemical class 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 description 42
- 239000000203 mixture Substances 0.000 description 18
- 230000008467 tissue growth Effects 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 9
- 238000004132 cross linking Methods 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 210000001503 joint Anatomy 0.000 description 7
- 210000003127 knee Anatomy 0.000 description 7
- 230000000399 orthopedic effect Effects 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 239000003431 cross linking reagent Substances 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 201000008482 osteoarthritis Diseases 0.000 description 6
- 230000001590 oxidative effect Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 210000001612 chondrocyte Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000004971 Cross linker Substances 0.000 description 4
- 102000014429 Insulin-like growth factor Human genes 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000017423 tissue regeneration Effects 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 206010060820 Joint injury Diseases 0.000 description 3
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 3
- 210000004095 humeral head Anatomy 0.000 description 3
- 210000002758 humerus Anatomy 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 2
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 2
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 2
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 208000016593 Knee injury Diseases 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 210000001188 articular cartilage Anatomy 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 230000002648 chondrogenic effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 210000004276 hyalin Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011005 laboratory method Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 229940033618 tisseel Drugs 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UBWXUGDQUBIEIZ-UHFFFAOYSA-N (13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl) 3-phenylpropanoate Chemical compound CC12CCC(C3CCC(=O)C=C3CC3)C3C1CCC2OC(=O)CCC1=CC=CC=C1 UBWXUGDQUBIEIZ-UHFFFAOYSA-N 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- BMFMQGXDDJALKQ-BYPYZUCNSA-N Argininic acid Chemical compound NC(N)=NCCC[C@H](O)C(O)=O BMFMQGXDDJALKQ-BYPYZUCNSA-N 0.000 description 1
- 108010081589 Becaplermin Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 108010049951 Bone Morphogenetic Protein 3 Proteins 0.000 description 1
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
- 108010049976 Bone Morphogenetic Protein 5 Proteins 0.000 description 1
- 108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 description 1
- 102100028728 Bone morphogenetic protein 1 Human genes 0.000 description 1
- 108090000654 Bone morphogenetic protein 1 Proteins 0.000 description 1
- 102100024504 Bone morphogenetic protein 3 Human genes 0.000 description 1
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
- 102100022526 Bone morphogenetic protein 5 Human genes 0.000 description 1
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 102000004427 Collagen Type IX Human genes 0.000 description 1
- 108010042106 Collagen Type IX Proteins 0.000 description 1
- 102000030746 Collagen Type X Human genes 0.000 description 1
- 108010022510 Collagen Type X Proteins 0.000 description 1
- 102000009736 Collagen Type XI Human genes 0.000 description 1
- 108010034789 Collagen Type XI Proteins 0.000 description 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000289669 Erinaceus europaeus Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241001653121 Glenoides Species 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102000014015 Growth Differentiation Factors Human genes 0.000 description 1
- 108010050777 Growth Differentiation Factors Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108010002616 Interleukin-5 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 208000003947 Knee Osteoarthritis Diseases 0.000 description 1
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- 241000051107 Paraechinus aethiopicus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 1
- 102000011117 Transforming Growth Factor beta2 Human genes 0.000 description 1
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 1
- 101800000304 Transforming growth factor beta-2 Proteins 0.000 description 1
- 102000056172 Transforming growth factor beta-3 Human genes 0.000 description 1
- 108090000097 Transforming growth factor beta-3 Proteins 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 229940047120 colony stimulating factors Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 210000001513 elbow Anatomy 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
- 238000002430 laser surgery Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 108010017843 platelet-derived growth factor A Proteins 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000002278 reconstructive surgery Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002832 shoulder Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 210000003857 wrist joint Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Composite Materials (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74802705P | 2005-12-07 | 2005-12-07 | |
| PCT/US2006/046576 WO2007067637A2 (en) | 2005-12-07 | 2006-12-07 | Cartilage repair methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009518132A true JP2009518132A (ja) | 2009-05-07 |
| JP2009518132A5 JP2009518132A5 (https=) | 2010-01-28 |
Family
ID=38123465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008544482A Pending JP2009518132A (ja) | 2005-12-07 | 2006-12-07 | 軟骨修復方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8444968B2 (https=) |
| EP (1) | EP1973554B1 (https=) |
| JP (1) | JP2009518132A (https=) |
| CA (1) | CA2631520A1 (https=) |
| ES (1) | ES2528272T3 (https=) |
| WO (1) | WO2007067637A2 (https=) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI464579B (zh) * | 2009-12-10 | 2014-12-11 | Intel Corp | 可編程循環冗餘檢查（ｃｒｃ）計算之指令集架構 |
| JP2016500020A (ja) * | 2012-11-16 | 2016-01-07 | イスト・テクノロジーズ・インコーポレイテッドＩｓｔｏ Ｔｅｃｈｎｏｌｏｇｉｅｓ， Ｉｎｃ． | 柔軟な組織マトリックス関連出願への相互参照本出願は、その開示全体が参照によって本明細書に組み入れられる「柔軟な組織マトリックス」と題する２０１２年１１月１６日に出願された米国仮特許出願第６１／７２７，４５４号の優先権を主張する。 |
| JP2017510376A (ja) * | 2014-04-08 | 2017-04-13 | アントニオ・サンブッセティＡｎｔｏｎｉｏ ＳＡＭＢＵＳＳＥＴＩ | 軟骨再構成用の再吸収性デバイス |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0896825B1 (en) * | 1997-08-14 | 2002-07-17 | Sulzer Innotec Ag | Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors |
| US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
| US7763769B2 (en) | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
| US7622562B2 (en) | 2002-06-26 | 2009-11-24 | Zimmer Orthobiologics, Inc. | Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue |
| US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
| US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
| US7824711B2 (en) | 2003-12-11 | 2010-11-02 | Isto Technologies, Inc. | Particulate cartilage system |
| US8192759B2 (en) * | 2004-07-12 | 2012-06-05 | Isto Technologies, Inc. | Matrix made of polyester polymers entangled with hyaluronic polymers useful for supporting tissue repair |
| US8512730B2 (en) | 2004-07-12 | 2013-08-20 | Isto Technologies, Inc. | Methods of tissue repair and compositions therefor |
| US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
| US20090319045A1 (en) | 2004-10-12 | 2009-12-24 | Truncale Katherine G | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
| JP5292533B2 (ja) | 2005-08-26 | 2013-09-18 | ジンマー・インコーポレイテッド | インプラントおよび関節疾患の治療、置換および治療方法 |
| CA2623106C (en) | 2005-09-19 | 2013-12-24 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
| EP1764117A1 (en) * | 2005-09-20 | 2007-03-21 | Zimmer GmbH | Implant for the repair of a cartilage defect and method for manufacturing the implant |
| ES2528272T3 (es) | 2005-12-07 | 2015-02-06 | Isto Technologies Inc. | Métodos de reparación de cartílago |
| US20080138414A1 (en) * | 2006-12-08 | 2008-06-12 | Smith & Nephew, Inc. | Methods of Regenerating Cartilage |
| US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
| US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
| AU2008240191B2 (en) | 2007-04-12 | 2013-09-19 | Zimmer, Inc. | Compositions and methods for tissue repair |
| US9119605B2 (en) | 2010-05-06 | 2015-09-01 | Zimmer, Inc. | Synthetic polymer adhesives and methods for making, using and delivering the same |
| AU2012275335B2 (en) | 2011-06-29 | 2017-04-20 | Biorestorative Therapies, Inc. | Brown fat cell compositions and methods |
| AU2012323963B2 (en) * | 2011-10-13 | 2017-10-12 | Solventum Intellectual Properties Company | Stimulation of cartilage repair using reduced pressure treatment |
| US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
| AU2014253920B2 (en) | 2013-04-19 | 2019-07-04 | Biorestorative Therapies, Inc. | Human brown adipose derived stem cells and uses |
| EP3197496B1 (en) | 2014-09-23 | 2021-05-26 | Cytex Therapeutics, Inc. | Articular cartilage repair |
| US10179191B2 (en) | 2014-10-09 | 2019-01-15 | Isto Technologies Ii, Llc | Flexible tissue matrix and methods for joint repair |
| US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
| US10524774B2 (en) | 2015-04-02 | 2020-01-07 | Arthrex, Inc. | Method of repairing cartilage defects |
| US10524775B2 (en) | 2015-07-02 | 2020-01-07 | Arthrex, Inc. | Methods of repairing cartilage defects |
| KR102355223B1 (ko) | 2016-05-16 | 2022-01-25 | 아스렉스, 인코퍼레이티드 | 무릎 관절낭 파열 및 복구 |
| US10022231B2 (en) | 2016-07-22 | 2018-07-17 | Cytex Therapeutics, Inc. | Articular cartilage repair |
| JP7480454B2 (ja) * | 2018-06-05 | 2024-05-10 | メディポスト・カンパニー・リミテッド | 有効成分として間葉系幹細胞を含む炎症性疾患の予防又は治療のための医薬組成物 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04505717A (ja) * | 1989-04-17 | 1992-10-08 | バカンティ，ジョセフ ピー | 細胞培養物からのインビボでの軟骨の新生 |
| JPH08504841A (ja) * | 1992-07-03 | 1996-05-28 | ミニステーロ・デル・ウニベルシタ・エ・デルラ・リシェルカ・シエンティフィカ・エ・テクノロジカ | 相互貫入ポリマー網（ｉｐｎ）におけるヒアルロン酸およびその誘導体 |
| JPH10500589A (ja) * | 1994-05-13 | 1998-01-20 | ティーエイチエム・バイオメディカル・インコーポレイテッド | 異なる多種多様な組織細胞を生体内で培養するための装置及び方法 |
| JP2005500085A (ja) * | 2001-01-30 | 2005-01-06 | オーソジーン， インコーポレイテッド | 滑膜由来の組織または細胞を使用する関節軟骨における欠陥または病変の処置および修復のための組成物および方法 |
| JP2005152653A (ja) * | 2003-11-26 | 2005-06-16 | Depuy Mitek Inc | 組織修復インプラント、その製造方法および組織修復方法 |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4438102A (en) | 1982-08-10 | 1984-03-20 | Ciro's Touch, Ltd. | Method of promoting tissue growth |
| US4692371A (en) | 1985-07-30 | 1987-09-08 | Kimberly-Clark Corporation | High temperature method of making elastomeric materials and materials obtained thereby |
| IT1198449B (it) | 1986-10-13 | 1988-12-21 | F I D I Farmaceutici Italiani | Esteri di alcoli polivalenti di acido ialuronico |
| US5736372A (en) | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
| US5290552A (en) | 1988-05-02 | 1994-03-01 | Matrix Pharmaceutical, Inc./Project Hear | Surgical adhesive material |
| WO1993000050A1 (en) | 1991-06-21 | 1993-01-07 | Genetics Institute, Inc. | Pharmaceutical formulations of osteogenic proteins |
| ITPD940054A1 (it) | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
| US20030086975A1 (en) | 2001-11-08 | 2003-05-08 | Timothy Ringeisen | Method for making a porous Polymeric material |
| US5769899A (en) | 1994-08-12 | 1998-06-23 | Matrix Biotechnologies, Inc. | Cartilage repair unit |
| US5906934A (en) * | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
| US5700289A (en) | 1995-10-20 | 1997-12-23 | North Shore University Hospital Research Corporation | Tissue-engineered bone repair using cultured periosteal cells |
| IT1282207B1 (it) | 1995-11-20 | 1998-03-16 | Fidia Advanced Biopolymers Srl | Sistemi di coltura di cellule staminali di midollo osseo umano in matrici tridimensionali costituiti da esteri dell'acido ialuronico |
| US5842477A (en) | 1996-02-21 | 1998-12-01 | Advanced Tissue Sciences, Inc. | Method for repairing cartilage |
| US5916585A (en) | 1996-06-03 | 1999-06-29 | Gore Enterprise Holdings, Inc. | Materials and method for the immobilization of bioactive species onto biodegradable polymers |
| US5866165A (en) | 1997-01-15 | 1999-02-02 | Orquest, Inc. | Collagen-polysaccharide matrix for bone and cartilage repair |
| ES2205467T3 (es) | 1997-03-31 | 2004-05-01 | The Regents Of The University Of Michigan | Matrices biodegradables de poros abiertos. |
| DE69809892T2 (de) | 1997-04-04 | 2003-08-28 | Fidia Advanced Biopolymers S.R.L., Brindisi | N-sulfatierte hyaluronsäureverbindungen, ihre derivate und verfahren zu ihrer herstellung |
| WO1999001143A1 (en) | 1997-07-03 | 1999-01-14 | Orquest, Inc. | Cross-linked polysaccharide drug carrier |
| CA2212300A1 (en) | 1997-08-04 | 1999-02-04 | Abdellatif Chenite | In vitro or in vivo gelfying chitosan and therapeutic uses thereof |
| US6395253B2 (en) * | 1998-04-23 | 2002-05-28 | The Regents Of The University Of Michigan | Microspheres containing condensed polyanionic bioactive agents and methods for their production |
| WO2000021470A1 (en) * | 1998-10-12 | 2000-04-20 | Therics, Inc. | Composites for tissue regeneration and methods of manufacture thereof |
| US6328765B1 (en) | 1998-12-03 | 2001-12-11 | Gore Enterprise Holdings, Inc. | Methods and articles for regenerating living tissue |
| US6663870B2 (en) | 1998-12-07 | 2003-12-16 | Zymogenetics, Inc. | Methods for promoting growth of bone using zvegf3 |
| US6696073B2 (en) | 1999-02-23 | 2004-02-24 | Osteotech, Inc. | Shaped load-bearing osteoimplant and methods of making same |
| IT1306644B1 (it) | 1999-04-08 | 2001-10-02 | Fidia Advanced Biopolymers Srl | Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico. |
| AU5701200A (en) | 1999-07-02 | 2001-01-22 | Petrus Besselink | Reinforced expandable cage |
| US20020095157A1 (en) | 1999-07-23 | 2002-07-18 | Bowman Steven M. | Graft fixation device combination |
| AU1618201A (en) | 1999-11-19 | 2001-05-30 | Children's Medical Center Corporation | Methods for inducing chondrogenesis and producing de novo cartilage in vitro |
| CA2402191C (en) | 2000-03-24 | 2012-03-13 | Genentech, Inc. | Use of insulin for the treatment of cartilagenous disorders |
| WO2001087575A2 (en) | 2000-05-12 | 2001-11-22 | The Regents Of The University Of Michigan | Reverse fabrication of porous materials |
| JP2004504835A (ja) * | 2000-07-29 | 2004-02-19 | スミス アンド ネフュー ピーエルシー | 組織インプラント |
| US6748954B2 (en) | 2000-10-27 | 2004-06-15 | The Regents Of The University Of Michigan | Drug release from polymer matrices through mechanical stimulation |
| DE10111767B4 (de) | 2001-03-12 | 2005-03-24 | Schwarz Pharma Ag | Verfahren zur Herstellung von Polyestern aus Hydroxycarbonsäuren und Polyolen durch Polykondensation |
| JP4500898B2 (ja) | 2001-03-23 | 2010-07-14 | 高木産業株式会社 | 生物学的組織および組織構築物を製造するための組成物および方法 |
| US7128760B2 (en) | 2001-03-27 | 2006-10-31 | Warsaw Orthopedic, Inc. | Radially expanding interbody spinal fusion implants, instrumentation, and methods of insertion |
| US6626950B2 (en) * | 2001-06-28 | 2003-09-30 | Ethicon, Inc. | Composite scaffold with post anchor for the repair and regeneration of tissue |
| US7252837B2 (en) | 2002-06-28 | 2007-08-07 | Ethicon, Inc. | Hemostatic wound dressing and method of making same |
| US20040078090A1 (en) | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
| US20040126405A1 (en) | 2002-12-30 | 2004-07-01 | Scimed Life Systems, Inc. | Engineered scaffolds for promoting growth of cells |
| FI20045223A7 (fi) | 2004-06-15 | 2005-12-16 | Bioretec Oy | Monitoiminen biohajoava komposiitti ja kirurginen implantti, joka käsittää mainitun komposiitin |
| US20050148512A1 (en) | 2003-11-10 | 2005-07-07 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
| US7446131B1 (en) | 2004-06-10 | 2008-11-04 | The United States Of America As Represented By The Secretary Of Agriculture | Porous polymeric matrices made of natural polymers and synthetic polymers and optionally at least one cation and methods of making |
| US8192759B2 (en) * | 2004-07-12 | 2012-06-05 | Isto Technologies, Inc. | Matrix made of polyester polymers entangled with hyaluronic polymers useful for supporting tissue repair |
| ATE524121T1 (de) | 2004-11-24 | 2011-09-15 | Abdou Samy | Vorrichtungen zur platzierung eines orthopädischen intervertebralen implantats |
| ES2528272T3 (es) | 2005-12-07 | 2015-02-06 | Isto Technologies Inc. | Métodos de reparación de cartílago |
-
2006
- 2006-12-07 ES ES06839104.4T patent/ES2528272T3/es active Active
- 2006-12-07 CA CA002631520A patent/CA2631520A1/en not_active Abandoned
- 2006-12-07 JP JP2008544482A patent/JP2009518132A/ja active Pending
- 2006-12-07 WO PCT/US2006/046576 patent/WO2007067637A2/en not_active Ceased
- 2006-12-07 EP EP06839104.4A patent/EP1973554B1/en active Active
- 2006-12-07 US US11/635,265 patent/US8444968B2/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04505717A (ja) * | 1989-04-17 | 1992-10-08 | バカンティ，ジョセフ ピー | 細胞培養物からのインビボでの軟骨の新生 |
| JPH08504841A (ja) * | 1992-07-03 | 1996-05-28 | ミニステーロ・デル・ウニベルシタ・エ・デルラ・リシェルカ・シエンティフィカ・エ・テクノロジカ | 相互貫入ポリマー網（ｉｐｎ）におけるヒアルロン酸およびその誘導体 |
| JPH10500589A (ja) * | 1994-05-13 | 1998-01-20 | ティーエイチエム・バイオメディカル・インコーポレイテッド | 異なる多種多様な組織細胞を生体内で培養するための装置及び方法 |
| JP2005500085A (ja) * | 2001-01-30 | 2005-01-06 | オーソジーン， インコーポレイテッド | 滑膜由来の組織または細胞を使用する関節軟骨における欠陥または病変の処置および修復のための組成物および方法 |
| JP2005152653A (ja) * | 2003-11-26 | 2005-06-16 | Depuy Mitek Inc | 組織修復インプラント、その製造方法および組織修復方法 |
Non-Patent Citations (3)
| Title |
|---|
| JPN6012042007; Ｙｏｏ ＨＳ ｅｔ ａｌ．: 'Ｈｙａｌｕｒｏｎｉｃ ａｃｉｄ ｍｏｄｉｆｉｅｄ ｂｉｏｄｅｇｒａｄａｂｌｅ ｓｃａｆｆｏｌｄｓ ｆｏｒ ｃａｒｔｉｌａｇｅ ｔｉｓｓｕｅ ｅｎｇｉｎｅｅｒｉｎｇ．' Ｂｉｏｍａｔｅｒｉａｌｓ． Ｖｏｌ．２６ Ｎｏ．１４, 200505, ｐｐ．１９２５-１９３３ * |
| JPN6012042008; Ｓｏｌｃｈａｇａ ＬＡ ｅｔ ａｌ．: 'Ｒｅｐａｉｒ ｏｆ ｏｓｔｅｏｃｈｏｎｄｒａｌ ｄｅｆｅｃｔｓ ｗｉｔｈ ｈｙａｌｕｒｏｎａｎ- ａｎｄ ｐｏｌｙｅｓｔｅｒ-ｂａｓｅｄ ｓｃａｆｆｏｌｄｓ．' Ｏｓｔｅｏａｒｔｈｒｉｔｉｓ Ｃａｒｔｉｌａｇｅ． Ｖｏｌ．１３ Ｎｏ．４, 200504, ｐｐ．２９７-３０９ * |
| JPN6012042009; Ｕｅｍａｔｓｕ Ｋ ｅｔ ａｌ．: 'Ｃａｒｔｉｌａｇｅ ｒｅｇｅｎｅｒａｔｉｏｎ ｕｓｉｎｇ ｍｅｓｅｎｃｈｙｍａｌ ｓｔｅｍ ｃｅｌｌｓ ａｎｄ ａ ｔｈｒｅｅ-ｄｉｍｅｎｓｉｏｎａｌ ｐｏｌｙ-ｌａｃｔｉｃ-ｇｌｙｃｏｌｉｃ ａｃｉ' Ｂｉｏｍａｔｅｒｉａｌｓ． Ｖｏｌ．２６ Ｎｏ．２０, 200507, ｐｐ．４２７３-４２７９ * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI464579B (zh) * | 2009-12-10 | 2014-12-11 | Intel Corp | 可編程循環冗餘檢查（ｃｒｃ）計算之指令集架構 |
| JP2016500020A (ja) * | 2012-11-16 | 2016-01-07 | イスト・テクノロジーズ・インコーポレイテッドＩｓｔｏ Ｔｅｃｈｎｏｌｏｇｉｅｓ， Ｉｎｃ． | 柔軟な組織マトリックス関連出願への相互参照本出願は、その開示全体が参照によって本明細書に組み入れられる「柔軟な組織マトリックス」と題する２０１２年１１月１６日に出願された米国仮特許出願第６１／７２７，４５４号の優先権を主張する。 |
| JP2017510376A (ja) * | 2014-04-08 | 2017-04-13 | アントニオ・サンブッセティＡｎｔｏｎｉｏ ＳＡＭＢＵＳＳＥＴＩ | 軟骨再構成用の再吸収性デバイス |
| US10898615B2 (en) | 2014-04-08 | 2021-01-26 | Antonio Sambusseti | Resorbable device for the reconstruction of cartilage |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1973554A4 (en) | 2009-11-25 |
| US8444968B2 (en) | 2013-05-21 |
| WO2007067637A3 (en) | 2008-12-24 |
| WO2007067637A2 (en) | 2007-06-14 |
| US20070128155A1 (en) | 2007-06-07 |
| EP1973554A2 (en) | 2008-10-01 |
| EP1973554B1 (en) | 2015-01-14 |
| ES2528272T3 (es) | 2015-02-06 |
| CA2631520A1 (en) | 2007-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009518132A (ja) | 軟骨修復方法 | |
| US11185576B2 (en) | Flexible tissue matrix and methods for joint repair | |
| US8512730B2 (en) | Methods of tissue repair and compositions therefor | |
| Smith et al. | The current state of scaffolds for musculoskeletal regenerative applications | |
| Clokie et al. | Reconstruction of 10 major mandibular defects using bioimplants containing BMP-7. | |
| JP6882361B2 (ja) | 細胞外マトリックス組織物質および骨原性タンパク質を含む生成物 | |
| US20110202142A1 (en) | Biologically derived composite tissue engineering | |
| JP4949241B2 (ja) | 組織マトリックスシステム | |
| CN102665604A (zh) | 用于组织修复的固体形式 | |
| Jung et al. | Multivalent ion-based in situ gelling polysaccharide hydrogel as an injectable bone graft | |
| KR20090101273A (ko) | 관절내 연골 및 골조직 치유를 위한 동일계 시스템 | |
| ES2676772T3 (es) | Reparación de tejidos mediante el uso de las células multipotentes | |
| US10179191B2 (en) | Flexible tissue matrix and methods for joint repair | |
| US20100093622A1 (en) | method of producing native components, such as growth factors or extracellular matrix proteins, through cell culturing of tissue samples for tissue repair | |
| Alfotawi et al. | Reconstruction of maxillofacial bone defects: Contemporary methods and future techniques | |
| Fattahian et al. | Biomaterials, substitutes, and tissue engineering in bone repair: Current and future concepts | |
| CN113749825A (zh) | 一种框架式骨关节假体及其制备方法和应用 | |
| Spinella et al. | Surgical repair of Achilles tendon rupture in dogs: a review of the literature, a case report and new perspectives | |
| RU2295980C1 (ru) | Имплантат для восстановления костной и/или хрящевой ткани и способ его получения | |
| JP2021534908A (ja) | 生体活性ガラスを含むマトリックス | |
| Giardino et al. | Bioabsorbable scaffold for in situ bone regeneration | |
| Gao et al. | 3D-printed regenerative polycaprolactone/silk fibroin osteogenic and chondrogenic implant for treatment of hip dysplasia | |
| Liu et al. | Applications of Decellularized Materials for Tissue Repair | |
| Berner | Quantitative and qualitative assessment of the regenerative potential of osteoblasts versus bone marrow derived mesenchymal stem cells in the reconstruction of critical sized segmental tibial bone defects in a large animal model | |
| Dias et al. | Mesenchymal Stem Cell Studies in the Goat Model for Biomedical Research—A Review of the Scientific Literature. Biology 2022, 11, 1276 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091204 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091204 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20110927 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120814 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20121113 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20121120 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20121213 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20121220 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130111 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130121 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130214 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130416 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130712 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130722 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130815 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130822 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130913 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130924 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20131210 |